S Foote.
Experienced Member
- Reaction score
- 66
I have not posted on the forums for a long time. But given the latest hype about PGd2 in male pattern baldness, i wish to point out something i think has been overlooked in the debate.
If PGD2 is significant in male pattern baldness, why do transplants survive in this sea of PGD2 in the bald area? The human samples used in the study came from areas not considered to be growth restricted by the androgen pathway. There is no evidence of any differences in how follicles react to PGD2, so how can this possibly be significant in male pattern baldness?
What happened to any responsible peer review of this paper? The problem with this kind of latest "cure" hype we get ever now and then, is the reaction of people on hair loss forums. People start to self medicate with often dangerous drugs. In my opinion, this is just another example of the poor science that has been the norm for many years in male pattern baldness research.
In my opinion male pattern baldness research has reached a dead end, simply because it has been based upon an untested assumpion. I dont want to seem negative here, but the only way forward is to be critical about the traditional assumptions that have got us nowhere in many years of trying.
Some here may remember my posts about my ideas relating to changes in follicle size based on evolution. This got to the point where i could go no further without professional scientific support, something that is not in the interest of anyone in the field. However developments continue to add weight to my argument.
I have recently written an updated article about my arguments involving hair growth, and a test proposal, This is linked on the Node website here:
http://thenode.biologists.com/a-consideration-of-mammalian-dermal-evolution/discussion/
In this i argue the case against some of the traditional assumptions that have been made in male pattern baldness, that continue to hold back progress towards better treatments. One recent study in particular effectively refutes the long held notion of the androgen pathway in male pattern baldness, reference 16 in my article.
If PGD2 is significant in male pattern baldness, why do transplants survive in this sea of PGD2 in the bald area? The human samples used in the study came from areas not considered to be growth restricted by the androgen pathway. There is no evidence of any differences in how follicles react to PGD2, so how can this possibly be significant in male pattern baldness?
What happened to any responsible peer review of this paper? The problem with this kind of latest "cure" hype we get ever now and then, is the reaction of people on hair loss forums. People start to self medicate with often dangerous drugs. In my opinion, this is just another example of the poor science that has been the norm for many years in male pattern baldness research.
In my opinion male pattern baldness research has reached a dead end, simply because it has been based upon an untested assumpion. I dont want to seem negative here, but the only way forward is to be critical about the traditional assumptions that have got us nowhere in many years of trying.
Some here may remember my posts about my ideas relating to changes in follicle size based on evolution. This got to the point where i could go no further without professional scientific support, something that is not in the interest of anyone in the field. However developments continue to add weight to my argument.
I have recently written an updated article about my arguments involving hair growth, and a test proposal, This is linked on the Node website here:
http://thenode.biologists.com/a-consideration-of-mammalian-dermal-evolution/discussion/
In this i argue the case against some of the traditional assumptions that have been made in male pattern baldness, that continue to hold back progress towards better treatments. One recent study in particular effectively refutes the long held notion of the androgen pathway in male pattern baldness, reference 16 in my article.